尚荣医疗: 更正公告

Core Viewpoint - Shenzhen Shangrong Medical Co., Ltd. has corrected its half-year performance forecast for 2025, indicating a significant expected loss compared to the previous year [1][2][3] Summary by Relevant Sections Performance Forecast - The company expects a net loss of between 7 million and 9.5 million yuan for the current reporting period, compared to a profit of 14.0266 million yuan in the same period last year [1] - The net profit attributable to shareholders is projected to decline by 149.91% to 167.73% compared to the previous year [1] - The loss after deducting non-recurring gains and losses is estimated to be between 11.6594 million and 14.1594 million yuan, with a significant decline of 604.98% to 713.25% compared to the previous year [1] - Basic earnings per share are expected to be a loss of 0.008 yuan to 0.011 yuan, compared to a profit of 0.0166 yuan per share in the previous year [1]